Bremelanotide (PT-141)

PT-141 is a research peptide that is also called Bremelanotide. It’s a non-selective agonist of all the melanocortin receptors, melanocortin receptor 1 to melanocortin receptor 5 (with the exception of melanocortin receptor 2, the receptor of Adrenocorticotropic hormone), but acting mainly as a melanocortin 3 receptor and melanocortin 4 receptor agonist.

It has shown great promise in scientific studies, helping improve sexual dysfunction, inflammation, regulating blood flow restriction on animal test subjects.

Bremelanotide was developed from the peptide called Melanotan II, which went through studies in a lab setting as a tanning drug, It’s from that scientific trial that the potential PT-141 benefits were discovered. Scientists have ascertained through a rigorous experiment on animal test subjects, due to its capability of regulating blood flow restriction plus inflammation by Bremelanotide, it may be helpful in managing the start of hemorrhagic shock as well as reperfusion injury.

That means it might potentially decrease or completely prevent inflammation that can be triggered by various diseases or irritants. In turn, that can also help reduce damages that could potentially take place within blood vessels plus surrounding tissue.

Also, additional studies have determined that this peptide is a potential solution for treating sexual dysfunction (sexual malfunction). Results from early studies have revealed that PT-141 doesn’t act on the circulatory system (vascular system) the way former compounds do, but it works by activating all the melanocortin receptors in your brain.